In our study, CD4/CD8 co-expression was seen in 50.2% cases, CD4/CD8 double negativity in 17.2%, CD4pos/CD8neg in 34.3% and CD8pos/CD4neg in 3.4% T-ALL cases. The gene discussed is CD4; the disease is acute lymphoblastic leukemia.